{"id":"W4379281468","doi":"10.1200/jco.2023.41.16_suppl.6005","title":"Dose expansion results of the bifunctional EGFR/TGFβ inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Clinical endpoint; Oncology; Head and neck squamous-cell carcinoma; Cohort; Progression-free survival; Response Evaluation Criteria in Solid Tumors; Head and neck cancer; Progressive disease; Chemotherapy; Cancer; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002296086,0.0009035954,0.001465903,0.0003870089,0.0003378457,0.0007087573,0.0006994425,0.0007963496,0.001587884],"category_scores_gemma":[0.001137008,0.0003327907,0.00119693,0.0003084533,0.0007260235,0.0007738187,0.0004941033,0.002000414,0.0005036288],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001264489,"about_ca_system_score_gemma":0.001194972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001099685,"about_ca_topic_score_gemma":0.001396159,"domain_scores_codex":[0.9990084,0.0004469942,0.000045389,0.0001857311,0.0001074752,0.0002061056],"domain_scores_gemma":[0.999223,0.0001247165,0.0001707742,0.0001411318,0.00005439368,0.0002859573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6062133,0.1381616,0.02886487,0.0002371552,0.001046844,0.0002871527,0.0005484358,0.006722056,0.1036788,0.0002083127,0.001937887,0.1120936],"study_design_scores_gemma":[0.04548912,0.8913243,0.04351635,0.00001284559,0.0006650331,0.0002085307,0.00008422309,0.002414383,0.01432921,0.0001132403,0.001815822,0.00002680189],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987042,0.0001735988,0.000139311,0.00003640807,0.00001176679,0.0004216949,0.0001912895,0.00001281009,0.0003088309],"genre_scores_gemma":[0.9971131,0.0001242489,0.0006480657,0.0001207462,0.00004758645,0.0005678927,0.0007439147,0.00001169114,0.000622729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002296086,"threshold_uncertainty_score":0.01214302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04420650303599501,"score_gpt":0.3784376208988284,"score_spread":0.3342311178628334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}